Target intelligence / Profile preview

Serine protease 40B (pseudogene) (PRSS40B)

Target: PRSS40B

Overview

Serine protease 40B (PRSS40B) is annotated as a human pseudogene. Although its name suggests it may encode a serine protease, genomic and database sources confirm it is a noncoding sequence and does not produce a functional enzyme or receptor. Pseudogenes are genomic DNA sequences similar to known genes but are typically nonfunctional due to mutations or lack of expression, and PRSS40B fits this category.

Other names: Serine protease 40B (pseudogene)PRSS40B

Mechanism of action

None. There are no mechanisms of action for drugs (due to lack of protein product)

Beyond the preview

Go deeper on Serine protease 40B (pseudogene) (PRSS40B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine protease 40B (pseudogene) (PRSS40B).

Explore the full profile